Products

IFF Pharma Solutions

45 Products found on IFF Pharma Solutions  in Topical

With SDS
With TDS
POLYOX™ WSR N 80NF TG LEO banner
IFF Pharma SolutionsPOLYOX™ WSR N 80NF TG LEO
  • Chemical Name:Polyethylene Oxide
  • CAS Number:25322-68-3
  • Functions:Lubricant (Internal), Film Former, Thickener, Flocculant, Viscosity Modifier, Binder, Lubricant, Controlled Release Agent
  • Dosage Form:Tablets, Abuse Deterrent Tablets & Capsules, Osmotic Pump Tablet, Gels
  • Labeling Claims:Chlorine-free, Nitrosamines-free, Vegetarian, Heavy Metal-free, Kosher, Naturally Derived, Vegan, TSE-free, Diethylene Glycol-free, Allergen-free, Residual Solvent -Free, Plant-Based, Not Listed In California Proposition 65, Ethylene Glycol-free, Oxidatively Degradable, Animal Products-free, Dairy-free, Not Tested on Animals, No Added Formaldehyde, Doping Substances-free, BSE-free, Halal, Non-GMO, Zinc-free
  • Certifications & Compliance:Japan Pharmacopeia (JP), Directive 2002/95/EC, ICH Q3D, EC No. 1935/2004, ISO 9001, Belgian Law And Codex Alimentarius Standards, Directive 1333/2008/EC, Halal, European Pharmacopeia (Ph. Eur.), EU Packaging Directive (94/62/EC), Regulation (EU) No. 1935/2004, United States Pharmacopeia (USP), EC No.1907/2006, Regulation (EC) No. 338/97, Directive 2011/65/EU (RoHS 2), CFDA Compliant (China), Japan DMF, EU Cosmetic Regulation 1223/2009 Compliant, ICH Q3C, Kosher, FFDCA, US DMF, National Formulary (NF), EC No. 2023/2006, EXCiPACT, Generally Recognized As Safe (GRAS), Clean Water Act (CWA) Certified, Regulation (EU) No. 10/2011 (PIM), Regulation (EU) No. 1829/2003, Directive 2001/83/EC, Directive 2009/48/EC, British Pharmacopeia (BP), Directive 2023/2055/EU, Regulation (EU) No. 1272/2008, Chinese Pharmacopeia (ChP), EU Directive 2002/72/EC, GMP, Regulation (EU) No. 1830/2003
  • Manufacturing Technology:Direct Compression
POLYOX™ WSR N 80NF TG LEO, in an off-white powder form, serves as a binder and thickener in cleaning and pharmaceutical formulations. Its water solubility makes it suitable for various applications, while its direct compression manufacturing technology ensures efficient production processes. Additionally, it functions as a controlled release agent, adding value to pharmaceutical formulations.
POLYOX™ WSR - N12K FP NF Grade banner
IFF Pharma SolutionsPOLYOX™ WSR - N12K FP NF Grade
  • Chemical Name:Polyethylene Oxide
  • CAS Number:25322-68-3
  • Functions:Lubricant (Internal), Film Former, Thickener, Flocculant, Viscosity Modifier, Binder, Lubricant, Controlled Release Agent
  • Dosage Form:Tablets, Abuse Deterrent Tablets & Capsules, Osmotic Pump Tablet, Gels
  • Labeling Claims:Chlorine-free, Nitrosamines-free, Vegetarian, Kosher, Vegan, TSE-free, Diethylene Glycol-free, Fungicide-free, Pesticide-free, Allergen-free, Residual Solvent -Free, Not Listed In California Proposition 65, Ethylene Glycol-free, Oxidatively Degradable, Animal Products-free, Dairy-free, Not Tested on Animals, Herbicide-free, Doping Substances-free, BSE-free, Halal, Non-GMO, Zinc-free, Gluten-free
  • Certifications & Compliance:Japan Pharmacopeia (JP), Directive 2002/95/EC, EC No. 1935/2004, ISO 9001, FDA Compliant, Belgian Law And Codex Alimentarius Standards, Directive 1333/2008/EC, European Pharmacopeia (Ph. Eur.), EU Packaging Directive (94/62/EC), Regulation (EU) No. 1935/2004, United States Pharmacopeia (USP), EC No.1907/2006, Regulation (EC) No. 338/97, Directive 2011/65/EU (RoHS 2), EU Cosmetic Regulation 1223/2009 Compliant, ICH Q3C, FFDCA, National Formulary (NF), EC No. 2023/2006, EXCiPACT, Generally Recognized As Safe (GRAS), Clean Water Act (CWA) Certified, Regulation (EU) No. 10/2011 (PIM), Regulation (EU) No. 1829/2003, Directive 2001/83/EC, Directive 2009/48/EC, British Pharmacopeia (BP), Directive 2023/2055/EU, Regulation (EU) No. 1272/2008, Chinese Pharmacopeia (ChP), EU Directive 2002/72/EC, GMP, Regulation (EU) No. 1830/2003
POLYOX™ WSR - N12K FP NF Grade composed of ethylene oxide copolymers and polyethylene oxide, serves diverse functions in pharmaceutical formulations. It finds application in abuse-deterrent tablets and capsules, gels, osmotic pump tablets, and regular tablets. This versatile ingredient acts as a binder, thickener, and controlled release agent, ensuring optimal performance. Available in powder form, it demonstrates water solubility, facilitating easy integration into formulations for enhanced effectiveness.
POLYOX™ N60K LEO NF HV banner
IFF Pharma SolutionsPOLYOX™ N60K LEO NF HV
  • Chemical Name:Polyethylene Oxide, Polyethylene Glycol, Pyrogenic Silica
  • CAS Number:25322-68-3
  • Functions:Lubricant (Internal), Film Former, Flocculant, Binder, Controlled Release Agent
  • Dosage Form:Tablets, Abuse Deterrent Tablets & Capsules, Osmotic Pump Tablet, Gels
  • Labeling Claims:Chlorine-free, Nitrosamines-free, Vegetarian, Kosher, Vegan, TSE-free, Diethylene Glycol-free, Fungicide-free, Pesticide-free, Allergen-free, Residual Solvent -Free, Ethylene Glycol-free, Oxidatively Degradable, Irradiation-free, Animal Products-free, Dairy-free, Not Tested on Animals, Ethylene Oxide-free, Herbicide-free, Doping Substances-free, VOC-free, BSE-free, Halal, Non-GMO, Zinc-free, Gluten-free
  • Certifications & Compliance:Japan Pharmacopeia (JP), Directive 2002/95/EC, EC No. 1935/2004, ISO 9001, FDA Compliant, Belgian Law And Codex Alimentarius Standards, Directive 1333/2008/EC, European Pharmacopeia (Ph. Eur.), EU Packaging Directive (94/62/EC), Regulation (EU) No. 1935/2004, United States Pharmacopeia (USP), EC No.1907/2006, Regulation (EC) No. 338/97, Directive 2011/65/EU (RoHS 2), EU Cosmetic Regulation 1223/2009 Compliant, ICH Q3C, FFDCA, National Formulary (NF), EC No. 2023/2006, EXCiPACT, Generally Recognized As Safe (GRAS), Regulation (EU) No. 10/2011 (PIM), Regulation (EU) No. 1829/2003, Directive 2001/83/EC, Directive 2009/48/EC, British Pharmacopeia (BP), Directive 2023/2055/EU, Regulation (EU) No. 1272/2008, Chinese Pharmacopeia (ChP), EU Directive 2002/72/EC, GMP, Regulation (EU) No. 1830/2003
POLYOX™ N60K LEO NF HV containing polyethylene oxide (PEG-45M) serves multiple functions in various applications. Its versatility extends to deterrent tablets and capsules, gels, osmotic pump tablets, and regular tablets. Functioning as a thickener, binder, and controlled release agent, it ensures optimal formulation performance. Available in powder form, it exhibits water solubility, enhancing its usability in diverse pharmaceutical formulations.
POLYOX™ WSR - 303 FP NF Grade banner
IFF Pharma SolutionsPOLYOX™ WSR - 303 FP NF Grade
  • Chemical Name:Polyethylene Oxide
  • CAS Number:25322-68-3
  • Functions:Lubricant (Internal), Film Former, Flocculant, Binder, Controlled Release Agent
  • Dosage Form:Tablets, Abuse Deterrent Tablets & Capsules, Osmotic Pump Tablet, Gels
  • Labeling Claims:Chlorine-free, Nitrosamines-free, Vegetarian, Heavy Metal-free, Kosher, Naturally Derived, Vegan, TSE-free, Diethylene Glycol-free, Allergen-free, Residual Solvent -Free, Plant-Based, Not Listed In California Proposition 65, Ethylene Glycol-free, Oxidatively Degradable, Animal Products-free, Dairy-free, Not Tested on Animals, No Added Formaldehyde, Doping Substances-free, BSE-free, Halal, Non-GMO, Zinc-free
  • Certifications & Compliance:Japan Pharmacopeia (JP), Directive 2002/95/EC, ICH Q3D, EC No. 1935/2004, ISO 9001, Belgian Law And Codex Alimentarius Standards, Directive 1333/2008/EC, Halal, European Pharmacopeia (Ph. Eur.), EU Packaging Directive (94/62/EC), Regulation (EU) No. 1935/2004, United States Pharmacopeia (USP), EC No.1907/2006, Regulation (EC) No. 338/97, Directive 2011/65/EU (RoHS 2), CFDA Compliant (China), Japan DMF, EU Cosmetic Regulation 1223/2009 Compliant, ICH Q3C, Kosher, FFDCA, US DMF, National Formulary (NF), EC No. 2023/2006, EXCiPACT, Generally Recognized As Safe (GRAS), Clean Water Act (CWA) Certified, Regulation (EU) No. 10/2011 (PIM), Regulation (EU) No. 1829/2003, Directive 2001/83/EC, Directive 2009/48/EC, British Pharmacopeia (BP), Directive 2023/2055/EU, Regulation (EU) No. 1272/2008, Chinese Pharmacopeia (ChP), EU Directive 2002/72/EC, GMP, Regulation (EU) No. 1830/2003
  • Manufacturing Technology:Direct Compression
POLYOX™ WSR - 303 FP NF Grade with its off-white powdered form, serves various functions in cleaning ingredients, acting as a binder and thickener. It finds application in diverse dosage forms such as gels, osmotic pump tablets, and conventional tablets, leveraging its water solubility and facilitating controlled release in pharmaceutical and nutraceutical formulations, manufactured through direct compression technology.
POLYOX™ WSR - 205 FP NF Grade banner
IFF Pharma SolutionsPOLYOX™ WSR - 205 FP NF Grade
  • Chemical Name:Polyethylene Oxide
  • CAS Number:25322-68-3
  • Functions:Lubricant (Internal), Film Former, Flocculant, Binder, Controlled Release Agent
  • Dosage Form:Tablets, Abuse Deterrent Tablets & Capsules, Osmotic Pump Tablet, Gels
  • Labeling Claims:Chlorine-free, Nitrosamines-free, Vegetarian, Kosher, Vegan, TSE-free, Diethylene Glycol-free, Fungicide-free, Pesticide-free, Allergen-free, Residual Solvent -Free, Not Listed In California Proposition 65, Ethylene Glycol-free, Oxidatively Degradable, Animal Products-free, Dairy-free, Not Tested on Animals, Herbicide-free, Doping Substances-free, BSE-free, Halal, Non-GMO, Zinc-free, Gluten-free
  • Certifications & Compliance:Japan Pharmacopeia (JP), Directive 2002/95/EC, EC No. 1935/2004, ISO 9001, FDA Compliant, Belgian Law And Codex Alimentarius Standards, Directive 1333/2008/EC, European Pharmacopeia (Ph. Eur.), EU Packaging Directive (94/62/EC), Regulation (EU) No. 1935/2004, United States Pharmacopeia (USP), EC No.1907/2006, Regulation (EC) No. 338/97, Directive 2011/65/EU (RoHS 2), EU Cosmetic Regulation 1223/2009 Compliant, ICH Q3C, FFDCA, National Formulary (NF), EC No. 2023/2006, EXCiPACT, Generally Recognized As Safe (GRAS), Clean Water Act (CWA) Certified, Regulation (EU) No. 10/2011 (PIM), Regulation (EU) No. 1829/2003, Directive 2001/83/EC, Directive 2009/48/EC, British Pharmacopeia (BP), Directive 2023/2055/EU, Regulation (EU) No. 1272/2008, Chinese Pharmacopeia (ChP), EU Directive 2002/72/EC, GMP, Regulation (EU) No. 1830/2003
POLYOX™ WSR - 205 FP NF Grade comprising ethylene oxide copolymers and polyethylene oxide (PEG-14M), serves multiple functions across various pharmaceutical applications. Its versatility extends to deterrent tablets and capsules, gels, osmotic pump tablets, and regular tablets. Functioning as a binder and thickener, it ensures optimal formulation performance. Available in powder form, it exhibits water solubility, facilitating ease of use in pharmaceutical formulations.
POLYOX™ WSR - 303 NF TG LEO banner
IFF Pharma SolutionsPOLYOX™ WSR - 303 NF TG LEO
  • Chemical Name:Polyethylene Oxide
  • CAS Number:25322-68-3
  • Functions:Lubricant (Internal), Film Former, Flocculant, Binder, Controlled Release Agent
  • Dosage Form:Tablets, Abuse Deterrent Tablets & Capsules, Osmotic Pump Tablet, Gels
  • Labeling Claims:Chlorine-free, Nitrosamines-free, Vegetarian, Heavy Metal-free, Kosher, Naturally Derived, Vegan, TSE-free, Diethylene Glycol-free, Allergen-free, Residual Solvent -Free, Plant-Based, Not Listed In California Proposition 65, Ethylene Glycol-free, Oxidatively Degradable, Animal Products-free, Dairy-free, Not Tested on Animals, No Added Formaldehyde, Doping Substances-free, BSE-free, Halal, Non-GMO, Zinc-free
  • Certifications & Compliance:Japan Pharmacopeia (JP), Directive 2002/95/EC, ICH Q3D, EC No. 1935/2004, ISO 9001, Belgian Law And Codex Alimentarius Standards, Directive 1333/2008/EC, Halal, European Pharmacopeia (Ph. Eur.), EU Packaging Directive (94/62/EC), Regulation (EU) No. 1935/2004, United States Pharmacopeia (USP), EC No.1907/2006, Regulation (EC) No. 338/97, Directive 2011/65/EU (RoHS 2), CFDA Compliant (China), Japan DMF, EU Cosmetic Regulation 1223/2009 Compliant, ICH Q3C, Kosher, FFDCA, US DMF, National Formulary (NF), EC No. 2023/2006, EXCiPACT, Generally Recognized As Safe (GRAS), Clean Water Act (CWA) Certified, Regulation (EU) No. 10/2011 (PIM), Regulation (EU) No. 1829/2003, Directive 2001/83/EC, Directive 2009/48/EC, British Pharmacopeia (BP), Directive 2023/2055/EU, Regulation (EU) No. 1272/2008, Chinese Pharmacopeia (ChP), EU Directive 2002/72/EC, GMP, Regulation (EU) No. 1830/2003
  • Manufacturing Technology:Direct Compression
POLYOX™ WSR - 303 NF TG LEO featuring an off-white color and a powder physical form, serves as a binder and thickener in various cleaning applications. It is formulated for use in gels, osmotic pump tablets, and conventional tablets, offering water solubility for effective performance.
POLYOX™ WSR Coagulant FP NF Grade banner
IFF Pharma SolutionsPOLYOX™ WSR Coagulant FP NF Grade
  • Chemical Name:Polyethylene Oxide, Pyrogenic Silica
  • CAS Number:25322-68-3
  • Functions:Lubricant (Internal), Film Former, Thickener, Flocculant, Viscosity Modifier, Binder, Lubricant, Controlled Release Agent
  • Dosage Form:Tablets, Abuse Deterrent Tablets & Capsules, Osmotic Pump Tablet, Gels
  • Labeling Claims:Chlorine-free, Nitrosamines-free, Vegetarian, Heavy Metal-free, Kosher, Naturally Derived, Vegan, TSE-free, Diethylene Glycol-free, Allergen-free, Residual Solvent -Free, Plant-Based, Ethylene Glycol-free, Oxidatively Degradable, Animal Products-free, Dairy-free, Not Tested on Animals, No Added Formaldehyde, Doping Substances-free, BSE-free, Halal, Non-GMO, Zinc-free
  • Certifications & Compliance:Japan Pharmacopeia (JP), Directive 2002/95/EC, ICH Q3D, EC No. 1935/2004, ISO 9001, Belgian Law And Codex Alimentarius Standards, Directive 1333/2008/EC, Halal, European Pharmacopeia (Ph. Eur.), EU Packaging Directive (94/62/EC), Regulation (EU) No. 1935/2004, United States Pharmacopeia (USP), EC No.1907/2006, Regulation (EC) No. 338/97, Directive 2011/65/EU (RoHS 2), CFDA Compliant (China), Japan DMF, EU Cosmetic Regulation 1223/2009 Compliant, ICH Q3C, Kosher, FFDCA, US DMF, National Formulary (NF), EC No. 2023/2006, EXCiPACT, Generally Recognized As Safe (GRAS), Regulation (EU) No. 10/2011 (PIM), Regulation (EU) No. 1829/2003, Directive 2001/83/EC, Directive 2009/48/EC, British Pharmacopeia (BP), Directive 2023/2055/EU, Regulation (EU) No. 1272/2008, Chinese Pharmacopeia (ChP), EU Directive 2002/72/EC, GMP, Regulation (EU) No. 1830/2003
  • Manufacturing Technology:Direct Compression
POLYOX™ WSR Coagulant FP NF Grade is an off-white to white powder that is water soluble. It is used in dosage forms such as abuse deterrent tablets, capsules, and gels, providing essential properties for these pharmaceutical applications.
POLYOX™ WSR - 303 LEO NF Grade HV Select banner
IFF Pharma SolutionsPOLYOX™ WSR - 303 LEO NF Grade HV Select
  • Chemical Name:Polyethylene Oxide
  • CAS Number:25322-68-3
  • Functions:Lubricant (Internal), Film Former, Flocculant, Binder, Controlled Release Agent
  • Dosage Form:Tablets, Abuse Deterrent Tablets & Capsules, Osmotic Pump Tablet, Gels
  • Labeling Claims:Chlorine-free, Nitrosamines-free, Vegetarian, Kosher, Vegan, TSE-free, Diethylene Glycol-free, Fungicide-free, Pesticide-free, Allergen-free, Residual Solvent -Free, Not Listed In California Proposition 65, Ethylene Glycol-free, Oxidatively Degradable, Animal Products-free, Dairy-free, Not Tested on Animals, Herbicide-free, Doping Substances-free, BSE-free, Halal, Non-GMO, Zinc-free, Gluten-free
  • Certifications & Compliance:Japan Pharmacopeia (JP), Directive 2002/95/EC, EC No. 1935/2004, ISO 9001, FDA Compliant, Belgian Law And Codex Alimentarius Standards, Directive 1333/2008/EC, European Pharmacopeia (Ph. Eur.), EU Packaging Directive (94/62/EC), Regulation (EU) No. 1935/2004, United States Pharmacopeia (USP), EC No.1907/2006, Regulation (EC) No. 338/97, Directive 2011/65/EU (RoHS 2), EU Cosmetic Regulation 1223/2009 Compliant, ICH Q3C, FFDCA, National Formulary (NF), EC No. 2023/2006, EXCiPACT, Generally Recognized As Safe (GRAS), Clean Water Act (CWA) Certified, Regulation (EU) No. 10/2011 (PIM), Regulation (EU) No. 1829/2003, Directive 2001/83/EC, Directive 2009/48/EC, British Pharmacopeia (BP), Directive 2023/2055/EU, Regulation (EU) No. 1272/2008, Chinese Pharmacopeia (ChP), EU Directive 2002/72/EC, GMP, Regulation (EU) No. 1830/2003
POLYOX™ WSR - 303 LEO NF Grade HV Select Amerchol composed of ethylene oxide copolymers and polyethylene oxide, serves diverse functions in pharmaceutical formulations. It finds application in abuse-deterrent tablets and capsules, gels, osmotic pump tablets, and regular tablets. This versatile ingredient acts as a binder, thickener, and controlled release agent, ensuring optimal performance. Available in powder form, it demonstrates water solubility, facilitating easy integration into formulations for enhanced effectiveness.
POLYOX™ WSR - N60K SFP NF Grade banner
IFF Pharma SolutionsPOLYOX™ WSR - N60K SFP NF Grade
  • Chemical Name:Polyethylene Oxide
  • CAS Number:25322-68-3
  • Functions:Lubricant (Internal), Film Former, Thickener, Flocculant, Viscosity Modifier, Binder, Lubricant, Controlled Release Agent
  • Dosage Form:Tablets, Abuse Deterrent Tablets & Capsules, Osmotic Pump Tablet, Gels
  • Labeling Claims:Chlorine-free, Nitrosamines-free, Vegetarian, Heavy Metal-free, Kosher, Naturally Derived, Vegan, TSE-free, Diethylene Glycol-free, Allergen-free, Residual Solvent -Free, Plant-Based, Not Listed In California Proposition 65, Ethylene Glycol-free, Oxidatively Degradable, Animal Products-free, Dairy-free, Not Tested on Animals, No Added Formaldehyde, Doping Substances-free, BSE-free, Halal, Non-GMO, Zinc-free
  • Certifications & Compliance:Japan Pharmacopeia (JP), Directive 2002/95/EC, ICH Q3D, EC No. 1935/2004, ISO 9001, Belgian Law And Codex Alimentarius Standards, Directive 1333/2008/EC, Halal, European Pharmacopeia (Ph. Eur.), EU Packaging Directive (94/62/EC), Regulation (EU) No. 1935/2004, United States Pharmacopeia (USP), EC No.1907/2006, Regulation (EC) No. 338/97, Directive 2011/65/EU (RoHS 2), CFDA Compliant (China), Japan DMF, EU Cosmetic Regulation 1223/2009 Compliant, ICH Q3C, Kosher, FFDCA, US DMF, National Formulary (NF), EC No. 2023/2006, EXCiPACT, Generally Recognized As Safe (GRAS), Clean Water Act (CWA) Certified, Regulation (EU) No. 10/2011 (PIM), Regulation (EU) No. 1829/2003, Directive 2001/83/EC, Directive 2009/48/EC, British Pharmacopeia (BP), Directive 2023/2055/EU, Regulation (EU) No. 1272/2008, Chinese Pharmacopeia (ChP), EU Directive 2002/72/EC, GMP, Regulation (EU) No. 1830/2003
  • Manufacturing Technology:Direct Compression
POLYOX™ WSR - N60K SFP NF Grade an off-white powder, offers versatile applications. Its industrial additives function as binders and thickeners, aiding in direct compression manufacturing. In pharmaceuticals, it acts as a binder and controlled release agent. Soluble in water, it suits abuse deterrent tablets & capsules, gels, and osmotic pump tablets.
POLYOX™ WSR - N80 FP NF Grade banner
IFF Pharma SolutionsPOLYOX™ WSR - N80 FP NF Grade
  • Chemical Name:Polyethylene Oxide
  • CAS Number:25322-68-3
  • Functions:Lubricant (Internal), Film Former, Thickener, Flocculant, Viscosity Modifier, Binder, Lubricant, Controlled Release Agent
  • Dosage Form:Tablets, Abuse Deterrent Tablets & Capsules, Osmotic Pump Tablet, Gels
  • Labeling Claims:Chlorine-free, Nitrosamines-free, Vegetarian, Heavy Metal-free, Kosher, Naturally Derived, Vegan, TSE-free, Diethylene Glycol-free, Allergen-free, Residual Solvent -Free, Plant-Based, Not Listed In California Proposition 65, Ethylene Glycol-free, Oxidatively Degradable, Animal Products-free, Dairy-free, Not Tested on Animals, No Added Formaldehyde, Doping Substances-free, BSE-free, Halal, Non-GMO, Zinc-free
  • Certifications & Compliance:Japan Pharmacopeia (JP), Directive 2002/95/EC, ICH Q3D, EC No. 1935/2004, ISO 9001, Belgian Law And Codex Alimentarius Standards, Directive 1333/2008/EC, Halal, European Pharmacopeia (Ph. Eur.), EU Packaging Directive (94/62/EC), Regulation (EU) No. 1935/2004, United States Pharmacopeia (USP), EC No.1907/2006, Regulation (EC) No. 338/97, Directive 2011/65/EU (RoHS 2), CFDA Compliant (China), Japan DMF, EU Cosmetic Regulation 1223/2009 Compliant, ICH Q3C, Kosher, FFDCA, US DMF, National Formulary (NF), EC No. 2023/2006, EXCiPACT, Generally Recognized As Safe (GRAS), Clean Water Act (CWA) Certified, Regulation (EU) No. 10/2011 (PIM), Regulation (EU) No. 1829/2003, Directive 2001/83/EC, Directive 2009/48/EC, British Pharmacopeia (BP), Directive 2023/2055/EU, Regulation (EU) No. 1272/2008, Chinese Pharmacopeia (ChP), EU Directive 2002/72/EC, GMP, Regulation (EU) No. 1830/2003
  • Manufacturing Technology:Direct Compression
POLYOX™ WSR - N80 FP NF Grade with its off-white color and powder form, exhibits versatile applications. In cosmetics, it functions as both a binder and a thickener, while in industrial additives, it serves similar purposes, offering water solubility for ease of use across various formulations.
POLYOX™ WSR - 301 FP NF Grade banner
IFF Pharma SolutionsPOLYOX™ WSR - 301 FP NF Grade
  • Chemical Name:Polyethylene Oxide
  • CAS Number:25322-68-3
  • Functions:Lubricant (Internal), Film Former, Thickener, Flocculant, Viscosity Modifier, Binder, Lubricant, Controlled Release Agent
  • Dosage Form:Tablets, Abuse Deterrent Tablets & Capsules, Osmotic Pump Tablet, Gels
  • Labeling Claims:Chlorine-free, Nitrosamines-free, Vegetarian, Heavy Metal-free, Kosher, Naturally Derived, Vegan, TSE-free, Diethylene Glycol-free, Allergen-free, Residual Solvent -Free, Plant-Based, Not Listed In California Proposition 65, Ethylene Glycol-free, Oxidatively Degradable, Animal Products-free, Dairy-free, Not Tested on Animals, No Added Formaldehyde, Doping Substances-free, BSE-free, Halal, Non-GMO, Zinc-free
  • Certifications & Compliance:Japan Pharmacopeia (JP), Directive 2002/95/EC, ICH Q3D, EC No. 1935/2004, ISO 9001, Belgian Law And Codex Alimentarius Standards, Directive 1333/2008/EC, Halal, European Pharmacopeia (Ph. Eur.), EU Packaging Directive (94/62/EC), Regulation (EU) No. 1935/2004, United States Pharmacopeia (USP), EC No.1907/2006, Regulation (EC) No. 338/97, Directive 2011/65/EU (RoHS 2), CFDA Compliant (China), Japan DMF, EU Cosmetic Regulation 1223/2009 Compliant, ICH Q3C, Kosher, FFDCA, US DMF, National Formulary (NF), EC No. 2023/2006, EXCiPACT, Generally Recognized As Safe (GRAS), Clean Water Act (CWA) Certified, Regulation (EU) No. 10/2011 (PIM), Regulation (EU) No. 1829/2003, Directive 2001/83/EC, Directive 2009/48/EC, British Pharmacopeia (BP), Directive 2023/2055/EU, Regulation (EU) No. 1272/2008, Chinese Pharmacopeia (ChP), EU Directive 2002/72/EC, GMP, Regulation (EU) No. 1830/2003
  • Manufacturing Technology:Direct Compression
POLYOX™ WSR - 301 FP NF Grade characterized by its off-white color, serves as a binder and thickener in cosmetic formulations. It is available in powder form and exhibits water solubility. Its versatility extends to various dosage forms including abuse deterrent tablets & capsules, gels, and osmotic pump tablets.
POLYOX™ WSR - N750 NF Grade banner
IFF Pharma SolutionsPOLYOX™ WSR - N750 NF Grade
  • Chemical Name:Polyethylene Oxide
  • CAS Number:25322-68-3
  • Functions:Lubricant (Internal), Film Former, Thickener, Flocculant, Viscosity Modifier, Binder, Lubricant, Controlled Release Agent
  • Dosage Form:Tablets, Abuse Deterrent Tablets & Capsules, Osmotic Pump Tablet, Gels
  • Labeling Claims:Chlorine-free, Nitrosamines-free, Vegetarian, Heavy Metal-free, Kosher, Naturally Derived, Vegan, TSE-free, Diethylene Glycol-free, Allergen-free, Residual Solvent -Free, Plant-Based, Not Listed In California Proposition 65, Ethylene Glycol-free, Oxidatively Degradable, Animal Products-free, Dairy-free, Not Tested on Animals, No Added Formaldehyde, Doping Substances-free, BSE-free, Halal, Non-GMO, Zinc-free
  • Certifications & Compliance:Japan Pharmacopeia (JP), Directive 2002/95/EC, ICH Q3D, EC No. 1935/2004, ISO 9001, Belgian Law And Codex Alimentarius Standards, Directive 1333/2008/EC, Halal, European Pharmacopeia (Ph. Eur.), EU Packaging Directive (94/62/EC), Regulation (EU) No. 1935/2004, United States Pharmacopeia (USP), EC No.1907/2006, Regulation (EC) No. 338/97, Directive 2011/65/EU (RoHS 2), CFDA Compliant (China), Japan DMF, EU Cosmetic Regulation 1223/2009 Compliant, ICH Q3C, Kosher, FFDCA, US DMF, National Formulary (NF), EC No. 2023/2006, EXCiPACT, Generally Recognized As Safe (GRAS), Clean Water Act (CWA) Certified, Regulation (EU) No. 10/2011 (PIM), Regulation (EU) No. 1829/2003, Directive 2001/83/EC, Directive 2009/48/EC, British Pharmacopeia (BP), Directive 2023/2055/EU, Regulation (EU) No. 1272/2008, Chinese Pharmacopeia (ChP), EU Directive 2002/72/EC, GMP, Regulation (EU) No. 1830/2003
  • Manufacturing Technology:Direct Compression
POLYOX™ WSR - N750 NF Grade is available in various dosage forms including gels, osmotic pump tablets, and traditional tablets. Utilizing direct compression manufacturing technology, it serves applications in both oral and topical drug delivery within the healthcare and pharmaceutical markets. With its properties as a binder and thickener, this white, water-soluble powder aids in formulation processes.
POLYOX™ WSR - 301 LEO NF Grade banner
IFF Pharma SolutionsPOLYOX™ WSR - 301 LEO NF Grade
  • Chemical Name:Polyethylene Oxide
  • CAS Number:25322-68-3
  • Functions:Lubricant (Internal), Film Former, Flocculant, Binder, Controlled Release Agent
  • Dosage Form:Tablets, Abuse Deterrent Tablets & Capsules, Osmotic Pump Tablet, Gels
  • Labeling Claims:Chlorine-free, Nitrosamines-free, Vegetarian, Heavy Metal-free, Kosher, Naturally Derived, Vegan, TSE-free, Diethylene Glycol-free, Allergen-free, Residual Solvent -Free, Plant-Based, Not Listed In California Proposition 65, Ethylene Glycol-free, Oxidatively Degradable, Animal Products-free, Dairy-free, Not Tested on Animals, No Added Formaldehyde, Doping Substances-free, BSE-free, Halal, Non-GMO, Zinc-free
  • Certifications & Compliance:Japan Pharmacopeia (JP), Directive 2002/95/EC, ICH Q3D, EC No. 1935/2004, ISO 9001, Belgian Law And Codex Alimentarius Standards, Directive 1333/2008/EC, Halal, European Pharmacopeia (Ph. Eur.), EU Packaging Directive (94/62/EC), Regulation (EU) No. 1935/2004, United States Pharmacopeia (USP), EC No.1907/2006, Regulation (EC) No. 338/97, Directive 2011/65/EU (RoHS 2), CFDA Compliant (China), Japan DMF, EU Cosmetic Regulation 1223/2009 Compliant, ICH Q3C, Kosher, FFDCA, US DMF, National Formulary (NF), EC No. 2023/2006, EXCiPACT, Generally Recognized As Safe (GRAS), Clean Water Act (CWA) Certified, Regulation (EU) No. 10/2011 (PIM), Regulation (EU) No. 1829/2003, Directive 2001/83/EC, Directive 2009/48/EC, British Pharmacopeia (BP), Directive 2023/2055/EU, Regulation (EU) No. 1272/2008, Chinese Pharmacopeia (ChP), EU Directive 2002/72/EC, GMP, Regulation (EU) No. 1830/2003
  • Manufacturing Technology:Direct Compression
POLYOX™ WSR - 301 LEO NF Grade characterized by its off-white color, serves as a binder and thickener in cosmetic formulations. It is available in powder form and exhibits water solubility. Its versatility extends to various dosage forms including abuse deterrent tablets & capsules, gels, and osmotic pump tablets.
Avicel® RC - 591 banner
IFF Pharma SolutionsAvicel® RC - 591
  • Chemical Name:Cellulose, carboxymethyl ether, sodium salt, Cellulose, Microcrystalline
  • Dosage Form:Spray, Suspension, Lotions
  • Labeling Claims:Endocrine Disruptor-free, Perfluorooctanoic Acid-free, Glycerin-free, Triphenyl Tin Compounds-Free, Genotoxic-free, Plasticizer-free, Halal, Paraben-free, Aluminum-free, Preservative-free, Allergen-free, Monosodium Glutamate (MSG)-free, Aflatoxin-free, Zinc-free, PFOS-free, Nitrosamines-free, Hormones-free, Free of Major Allergens, PHO (Partially Hydrogenated Oil)-Free, Vegan, Caffeine Free, Kosher, Pesticide-free, Solvent-free, Antibiotics-free, Melamine-free, Colorants-free, Amine-free, Latex-free, Dioxin-free, Animal Products-free, GMO-free, Flavor Free, Natural Latex Rubber-Free, Not Listed In California Proposition 65, Phthalates-free, PFAS-Free, Non-GMO, PAH-free, Not Tested on Animals, Tributyl Tin Compounds-Free, Mercury-Free, TSE-free, Palm Oil-free, Vegetarian, Pareve, Ethylene Oxide-free, Bisphenol A-free, Generally Recognized As Safe (GRAS), APE-free, Irradiation-free, Gluten-free, BSE-free, Sugar-free, PVC-free, Dye Free, Dehp (Diethylhexyl Phthalate)-Free, Mycotoxins-free
  • Certifications & Compliance:FSSC 22000, Hazard Analysis Critical Control Point (HACCP), cGMP, Regulation (EU) No. 1272/2008, IFRA Compliant, Halal Food Council of Europe, EC No.1907/2006, FDA Food Safety Modernization Act (FSMA), Japan Pharmacopeia (JP), ICH Q3C, European Pharmacopeia (Ph. Eur.), JECFA (FAO/WHO), Kosher, Regulation (EC) No. 1334/2008, Regulation (EU) No. 1829/2003, GMP, Halal, Doping-Free, Halal, Central Islamic Council of Thailand, ISO 14001, National Formulary (NF), Directive 1169/2011/EC, Japanese Pharmaceutical Excipients (JPE), European Regulation 396/2005/EC, Regulation (EU) No. 231/2012, IFANCA Halal, EXCiPACT, ISO 9001, United States Pharmacopeia (USP), FDA Compliant, ISO 45001, Regulation (EU) No. 1830/2003, EU Cosmetic Regulation 1223/2009 Compliant, Generally Recognized As Safe (GRAS), Chinese Pharmacopeia (ChP), ISO 22000, Regulation (EU) No. 1881/2006, British Pharmacopeia (BP), Union of Orthodox Jewish Congregations of America Kosher
  • Manufacturing Technology:Wet Granulation, Dry Granulation, Direct Compression
Avicel® RC - 591 is versatile, catering to various dosage forms like lotions, sprays, and suspensions. Its manufacturing technology involves direct compression, dry granulation, and wet granulation methods. In pharmaceutical and nutraceutical applications, it serves as a binder, compression aid, immediate release agent, and stabilizer, ensuring product efficacy and stability.

Show

of 45 results